1. The non-steroidal mineralocorticoid receptor antagonist finerenone improves left ventricular function in preclinical chronic kidney disease. (14th October 2021) Authors: Stephan, Y; Lima-Posada, I; Souille, M; Bonnard, B; Palacios, R; Nicol, L; Kolkhof, P; Jaisser, F; Mulder, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗